Gritstone bio, Inc. - Common Stock, $0.0001 par value per share (GRTS)

CUSIP: 39868T105

Q3 2023 13F Holders as of 30 Sep 2023

Holder snapshot 7 signals
Share change
-2,345,274
Put/Call ratio
64%
SEC-reported price per share
$1.72
Number of holders
88
Value change
-$4,320,891
Number of buys
36
Open additional details 1 more signal available
Number of sells
37
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
160,529,963

Security key

39868T105

Report period

Q3 2023

Institutions

88

Top holders

10

Ownership snapshot

Top reported holders of GRTS - Gritstone bio, Inc. - Common Stock, $0.0001 par value per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
Point72 Asset Management,...
Disclosed value leader
Point72 Asset Management,...
Comparable rows
0/15
Latest evidence
30 Jun 2023
13F Highest disclosed value: $14,768,676 15 rows are not safely comparable across share classes. Showing 1-6 of 15 holder rows.

Quick read

Point72 Asset Management, L.P. has the largest disclosed position value at $14.77M.

0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Point72 Asset Management, L.P.'s linked filing trail.
Disclosed position value Top 5
Point72 Asset Management, L.P. $14.77M
Redmile Group, LLC $13.38M
BlackRock Finance, Inc. $12.12M
VANGUARD GROUP INC $7.9M
Versant Venture Management, LLC $6.94M

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
Point72 Asset Management, L.P.
13F
Company
13F
—
denominator unverified
$14,768,676
7,573,680 shares
— 30 Jun 2023
Redmile Group, LLC
13F
Company
13F
—
denominator unverified
$13,377,441
6,860,226 shares
— 30 Jun 2023
BlackRock Finance, Inc.
13F
Company
13F
—
denominator unverified
$12,116,193
6,213,432 shares
— 30 Jun 2023
VANGUARD GROUP INC
13F
Company
13F
—
denominator unverified
$7,895,554
4,049,002 shares
— 30 Jun 2023
Versant Venture Management, LLC
13F
Company
13F
—
denominator unverified
$6,944,243
3,561,150 shares
— 30 Jun 2023
Avidity Partners Management LP
13F
Company
13F
—
denominator unverified
$5,392,725
2,765,500 shares
— 30 Jun 2023
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q3 2023

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
88
Shares
48,612,900
Rows available
88
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q3 2023 vs Q3 2025 Across Filers

Q3 2025 holders
1
Q3 2023 holders
88
Holder diff
87
Investor Q3 2025 Shares Q3 2023 Shares Share Diff Share Chg % Q3 2025 value Q3 2023 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .